To further validate the role of hepatocyte DDX17 in the development of NASH, we overexpressed DDX17 in 6‐week‐old mice by injection of an adeno‐associated virus expressing Ddx17 (AAV8‐Ddx17) in parallel with its control followed by MCD feeding for another 16 weeks (Figure 4A). The gene discussed is DDX17; the disease is metabolic dysfunction-associated steatohepatitis.